Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine.
作者信息
Flores Rebollar Armando
机构信息
Departamento de Medicina Interna, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán», Mexico City, Mexico.
出版信息
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Oct;40(8):459-460. doi: 10.1016/j.eimce.2022.05.008. Epub 2022 May 19.
Abstract
摘要
相似文献
1
Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine.
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Oct;40(8):459-460. doi: 10.1016/j.eimce.2022.05.008. Epub 2022 May 19.
2
Reply: Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine.回复：抗SARS-CoV-2（Ad5-nCoV）疫苗接种后亚急性甲状腺炎
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jun-Jul;40(6):345-346. doi: 10.1016/j.eimce.2022.03.005. Epub 2022 Apr 26.
3
Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.三例接种 SARS-CoV-2 疫苗后亚急性甲状腺炎：疫苗接种后 ASIA 综合征。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):2600-2605. doi: 10.1210/clinem/dgab373.
4
Response to Letter to the Editor From Raven: Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine.对《乌鸦》杂志编辑来信的回复：3例新型冠状病毒疫苗接种后亚急性甲状腺炎病例
J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1773-e1774. doi: 10.1210/clinem/dgab823.
5
Letter to the Editor From Raven et al: "Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine".来自拉文等人致编辑的信：“三例接种新型冠状病毒疫苗后发生的亚急性甲状腺炎”
J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1767-e1768. doi: 10.1210/clinem/dgab822.
6
Subacute thyroiditis after SARS-CoV-2 vaccination: report of two clinical cases.新型冠状病毒疫苗接种后亚急性甲状腺炎：两例临床病例报告。
Med Clin (Barc). 2022 Jun 24;158(12):e13-e14. doi: 10.1016/j.medcli.2021.11.002. Epub 2021 Nov 13.
7
Subacute thyroiditis after inactive SARS-CoV-2 vaccine.接种灭活 SARS-CoV-2 疫苗后发生亚急性甲状腺炎。
BMJ Case Rep. 2021 Oct 1;14(10):e244711. doi: 10.1136/bcr-2021-244711.
8
Subacute Thyroiditis Following SARS-CoV-2 Vaccines: Six Cases Report and Review of the Literature.接种 SARS-CoV-2 疫苗后的亚急性甲状腺炎：六例报告及文献复习。
Horm Metab Res. 2022 Aug;54(8):556-561. doi: 10.1055/a-1804-9561. Epub 2022 Mar 22.
9
Subacute thyroiditis after SARS-CoV2 vaccine: possible relapse after boosting.接种新型冠状病毒2型疫苗后发生亚急性甲状腺炎：加强免疫后可能复发。
J Endocrinol Invest. 2022 Oct;45(10):2019-2020. doi: 10.1007/s40618-022-01856-w. Epub 2022 Jul 5.
10
Silent thyroiditis following vaccination against COVID-19: report of two cases.接种 COVID-19 疫苗后发生静默性甲状腺炎：两例报告。
J Endocrinol Invest. 2022 May;45(5):1079-1083. doi: 10.1007/s40618-021-01725-y. Epub 2022 Jan 16.
引用本文的文献
1
SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review.严重急性呼吸综合征冠状病毒2型疫苗相关内分泌疾病：最新叙述性综述
Vaccines (Basel). 2024 Jul 8;12(7):750. doi: 10.3390/vaccines12070750.
2
Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine.SARS-CoV-2 相关亚急性甲状腺炎的研究进展：从感染到疫苗。
Virol J. 2023 Jun 21;20(1):132. doi: 10.1186/s12985-023-02103-1.
3
COVID-19 vaccination and thyroiditis.COVID-19 疫苗接种与甲状腺炎。
Best Pract Res Clin Endocrinol Metab. 2023 Jul;37(4):101759. doi: 10.1016/j.beem.2023.101759. Epub 2023 Mar 3.
4
Subacute thyroiditis after COVID-19 vaccination.新冠病毒疫苗接种后亚急性甲状腺炎
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jun-Jul;40(6):345. doi: 10.1016/j.eimce.2021.12.009.
5
Subacute thyroiditis after COVID-19 vaccination.新冠病毒疫苗接种后亚急性甲状腺炎
Enferm Infecc Microbiol Clin. 2022 Jun-Jul;40(6):345. doi: 10.1016/j.eimc.2021.12.010. Epub 2022 Jan 24.
本文引用的文献
1
Case Report: Two Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccination.病例报告：两例接种新型冠状病毒疫苗后发生的亚急性甲状腺炎
Front Med (Lausanne). 2021 Aug 24;8:737142. doi: 10.3389/fmed.2021.737142. eCollection 2021.
2
Subacute Thyroiditis After Receiving the Adenovirus-Vectored Vaccine for Coronavirus Disease (COVID-19).接种新型冠状病毒肺炎（COVID-19）腺病毒载体疫苗后发生的亚急性甲状腺炎
Cureus. 2021 Jun 29;13(6):e16045. doi: 10.7759/cureus.16045. eCollection 2021 Jun.
3
Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report.67 岁男性患者接种 COVID-19 疫苗后发生亚急性甲状腺炎：病例报告。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4090-4092. doi: 10.1080/21645515.2021.1947102. Epub 2021 Jul 1.
4
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.BNT162b2 mRNA COVID-19 疫苗在成年自身免疫性炎症性风湿病患者和普通人群中的免疫原性和安全性：一项多中心研究。
Ann Rheum Dis. 2021 Oct;80(10):1330-1338. doi: 10.1136/annrheumdis-2021-220647. Epub 2021 Jun 14.
5
Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.三例接种 SARS-CoV-2 疫苗后亚急性甲状腺炎：疫苗接种后 ASIA 综合征。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):2600-2605. doi: 10.1210/clinem/dgab373.
6
SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives.SARS-CoV-2 相关免疫炎症性甲状腺疾病：现状与展望。
Expert Rev Clin Immunol. 2021 Jul;17(7):737-759. doi: 10.1080/1744666X.2021.1932467. Epub 2021 Jun 2.
7
New aspects in the pathogenesis and management of subacute thyroiditis.亚急性甲状腺炎发病机制和治疗的新方面。
Rev Endocr Metab Disord. 2021 Dec;22(4):1027-1039. doi: 10.1007/s11154-021-09648-y. Epub 2021 May 5.
8
Adenovirus Vectors: Excellent Tools for Vaccine Development.腺病毒载体：疫苗开发的优秀工具。
Immune Netw. 2021 Feb 15;21(1):e6. doi: 10.4110/in.2021.21.e6. eCollection 2021 Feb.
9
Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突糖蛋白与哺乳动物蛋白质组之间的分子模拟：对疫苗的影响。
Immunol Res. 2020 Oct;68(5):310-313. doi: 10.1007/s12026-020-09152-6. Epub 2020 Sep 18.
10
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与人体组织之间潜在的抗原交叉反应性，可能与自身免疫性疾病增加有关。
Clin Immunol. 2020 Aug;217:108480. doi: 10.1016/j.clim.2020.108480. Epub 2020 May 24.
Zotero 插件